Sangui Biotech International (Sangui Biotech International) Net Margin %

: -200.00% (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Sangui Biotech International's Net Income for the three months ended in Mar. 2023 was $-0.04 Mil. Sangui Biotech International's Revenue for the three months ended in Mar. 2023 was $0.02 Mil. Therefore, Sangui Biotech International's net margin for the quarter that ended in Mar. 2023 was -200.00%.

The historical rank and industry rank for Sangui Biotech International's Net Margin % or its related term are showing as below:

SGBI's Net Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 3.765
* Ranked among companies with meaningful Net Margin % only.

Sangui Biotech International Net Margin % Historical Data

The historical data trend for Sangui Biotech International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Net Margin %

-262.34

-368.18

-665.52

-301.52

-85.51

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Net Margin %																-83.33	-63.64	56.10	-927.27	-200.00

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangui Biotech International Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Net Margin % falls into.

Sangui Biotech International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sangui Biotech International's Net Margin for the fiscal year that ended in Jun. 2022 is calculated as

Net Margin	=	Net Income (A: Jun. 2022 )	/	Revenue (A: Jun. 2022 )
	=	-0.059	/	0.069
	=	-85.51 %

Sangui Biotech International's Net Margin for the quarter that ended in Mar. 2023 is calculated as

Net Margin	=	Net Income (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-0.038	/	0.019
	=	-200.00 %

Sangui Biotech International (OTCPK:SGBI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Sangui Biotech International Net Margin % Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (Sangui Biotech International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

SBH:Germany

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

Executives

Hubertus Schmelz	director	NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing	director	ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe	director	NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol	director	ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim	director	ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz	director	SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines